Press Release

India Therapeutic Drug Monitoring Market to Grow with a CAGR of 8.18% through 2029

Rising advancement in technology and increase in drug development activities is expected to drive the India therapeutic drug monitoring market growth in the forecast period, 2025-2029.


According to TechSci Research report, “India Therapeutic Drug Monitoring Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the India Therapeutic Drug Monitoring Market stood at USD 50.41 Million in 2023 and is anticipated to grow with a CAGR of 8.18% in the forecast period, 2025-2029. The India Therapeutic Drug Monitoring Market is experiencing significant growth, driven by several key factors. The increasing prevalence of diseases requiring constant monitoring, such as epilepsy, heart disease, and certain autoimmune disorders, is a primary driver.

The rising awareness and acceptance of personalized medication plans, which often involve therapeutic drug monitoring, are also playing a critical role. Furthermore, advances in drug monitoring technologies and improvements in healthcare infrastructure are contributing to this burgeoning market. The increase in healthcare expenditure, both private and public, is enabling a larger patient population to avail of these services, thereby driving demand.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Therapeutic Drug Monitoring Market.”

India, the second-most populous country globally, is experiencing a significant surge in the therapeutic drug monitoring (TDM) market. TDM, which falls under the umbrella of clinical chemistry and clinical pharmacology, focuses on measuring medication concentrations in the bloodstream. This crucial branch plays a pivotal role in maintaining drug levels within a specific therapeutic range, optimizing drug efficiency, and minimizing adverse effects. Given the diverse population of India and the varying responses to medication, this careful management is of paramount importance.

The growth of the TDM market in India can be attributed to a combination of factors. The aging population is on the rise, leading to an increased demand for TDM services. The elderly are more susceptible to chronic diseases and require multiple medications, making TDM an essential component of their healthcare. Moreover, the prevalence of diseases such as diabetes, cancer, and tuberculosis has further underscored the need for TDM in delivering effective treatment regimens.

Furthermore, the rapid growth of the Indian pharmaceutical industry, coupled with government initiatives promoting healthcare accessibility, has stimulated the TDM market. India is globally recognized as a significant player in pharmaceuticals and is increasingly focused on bridging the gap between urban and rural healthcare. As a result, there is an amplified need for TDM, particularly in rural areas that previously had limited healthcare access.

However, the TDM market in India faces certain challenges. The high costs associated with TDM, along with a general lack of awareness about the importance of this practice, pose substantial hurdles. Additionally, regulatory complexities and the need for trained professionals to execute TDM also impede market growth.

Despite these challenges, the future of the TDM market in India looks promising, with abundant opportunities for growth. Continued advancements in technology and a greater emphasis on personalized medicine are expected to significantly increase the demand for TDM. The integration of artificial intelligence and machine learning in healthcare could open up new avenues for TDM, potentially revolutionizing the way medication is administered and monitored. The therapeutic drug monitoring market in India is on an upward trajectory, driven by various factors. The convergence of a growing elderly population, advancements in technology, and the emphasis on personalized medicine position India as a key player in the global TDM market. While challenges persist, the potential for TDM in India is vast, fostering optimism for its future growth and impact in the healthcare landscape.

The India Therapeutic Drug Monitoring Market is segmented into product, technology, class of drug, end user, regional distribution, and company.

Based on class of drug, antibiotic drugs are anticipated to have a significant and transformative impact on the India Therapeutic Drug Monitoring Market. This projection is rooted in the alarming rise in the prevalence of infectious diseases, particularly the emergence of antibiotic-resistant strains that pose a grave threat to public health. The urgent need for close monitoring and surveillance has become increasingly crucial in order to ensure optimal treatment outcomes and effectively curb the spread of these resistant infections. By closely monitoring antibiotic therapy, healthcare professionals can not only optimize dosing regimens but also make well-informed decisions, leveraging their expertise to combat the ever-evolving landscape of infectious diseases in India. This comprehensive approach aims to safeguard the health and well-being of the population by addressing the challenges posed by infectious diseases head-on, while also considering the unique nuances and complexities of the Indian healthcare system.

Through careful monitoring and surveillance, healthcare professionals can proactively identify patterns and trends in antibiotic resistance, which can inform the development of targeted interventions and guidelines. Additionally, this approach enables the identification of high-risk populations and regions, allowing for more focused efforts in prevention and containment. Furthermore, the integration of advanced technologies and data analytics can enhance the effectiveness of therapeutic drug monitoring, enabling real-time tracking of antibiotic use and resistance patterns. This can facilitate the early detection of emerging resistant strains and inform the development of proactive strategies to mitigate their impact. The integration of comprehensive therapeutic drug monitoring practices, including close monitoring of antibiotic therapy, is of paramount importance in the battle against infectious diseases in India. By embracing a multifaceted approach that combines clinical expertise, targeted interventions, and advanced technologies, we can better address the challenges posed by antibiotic resistance and safeguard the health and well-being of the population.

Based on region, North India is dominating the Indian Therapeutic Drug Monitoring Market due to various factors. Primarily, the region's large patient population and the prevalence of chronic diseases necessitate a high demand for therapeutic drug monitoring. Additionally, North India is home to some of the most reputed healthcare establishments in the country, equipped with advanced medical technology and skilled healthcare professionals. These facilities contribute significantly to the region's dominance in the market. Moreover, the favorable government policies and initiatives aimed at promoting healthcare infrastructure and advancements in medical research have further propelled the growth of therapeutic drug monitoring in North India. The region has witnessed an influx of investments in healthcare, leading to the establishment of state-of-the-art laboratories and specialized clinics dedicated to therapeutic drug monitoring.

Furthermore, the increased accessibility to healthcare services and the growing awareness about the importance of therapeutic drug monitoring in disease management have led to an upsurge in the demand for these services in North India. Patients and healthcare providers alike recognize the significant role that therapeutic drug monitoring plays in optimizing treatment outcomes and minimizing adverse drug reactions. With a comprehensive network of healthcare providers, cutting-edge technology, and a proactive approach towards healthcare, North India continues to lead the way in the Indian Therapeutic Drug Monitoring Market, setting new benchmarks for quality patient care and clinical excellence.


Major companies operating in India Therapeutic Drug Monitoring Market are:

  • Roche Diagnostics India Pvt. Ltd.
  • Abbott India Ltd
  • Bio-Merieux India Pvt. Ltd.
  • Bio-Rad laboratories India Pvt.Ltd
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Danaher India (DHR Holding India Pvt. Ltd.)
  • Siemens Healthineers India
  • Randox Laboratories Pvt. Ltd.
  • Sekisui Chemical Co. Ltd.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“The future of the therapeutic drug monitoring market in India appears to be highly promising, propelled by the escalating prevalence of chronic diseases and the growing adoption of personalized medicine. Remarkable technological advancements in drug monitoring devices, coupled with an increasing emphasis on early disease detection and prevention, are anticipated to significantly contribute to the market's growth trajectory. Additionally, the government's proactive initiatives to expand healthcare infrastructure and enhance access to healthcare services are expected to create a highly conducive environment for the expansion of the market. These factors collectively position the therapeutic drug monitoring market in India for a prosperous and impactful future.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

India Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (Immunoassays, Chromatography-Ms and Others), By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others), By End User (Hospitals, Private Labs), By Region, Competition, Forecast & Opportunities, 2019-2019F”, has evaluated the future growth potential of India Therapeutic Drug Monitoring Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Therapeutic Drug Monitoring Market.



Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]